ABBOTT INDIA
Quarterly Results Analysis [Jun2026]
ABBOTT INDIA Quarterly Results
| Standalone | Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹1,814 Cr | ₹1,710 Cr | ₹1,724 Cr | ₹1,757 Cr | ₹1,738 Cr | ₹1,605 Cr | ₹1,614 Cr | ₹1,633 Cr |
| Expenses | ₹1,291 Cr | ₹1,229 Cr | ₹1,261 Cr | ₹1,255 Cr | ₹1,293 Cr | ₹1,176 Cr | ₹1,178 Cr | ₹1,194 Cr |
| Operating Income | ₹523 Cr | ₹481 Cr | ₹463 Cr | ₹502 Cr | ₹446 Cr | ₹429 Cr | ₹436 Cr | ₹439 Cr |
| Other Income | ₹75 Cr | ₹76 Cr | ₹70 Cr | ₹70 Cr | ₹73 Cr | ₹76 Cr | ₹72 Cr | ₹60 Cr |
| Interest | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹8 Cr | ₹6 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr |
| Depreciation | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
| Profit Before Tax | ₹572 Cr | ₹531 Cr | ₹509 Cr | ₹546 Cr | ₹493 Cr | ₹483 Cr | ₹488 Cr | ₹479 Cr |
| Profit After Tax | ₹429 Cr | ₹395 Cr | ₹376 Cr | ₹415 Cr | ₹366 Cr | ₹367 Cr | ₹361 Cr | ₹359 Cr |
| EPS | ₹201.66 | ₹185.85 | ₹176.92 | ₹195.42 | ₹172.17 | ₹172.72 | ₹169.78 | ₹168.76 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ABBOTT INDIA | -1.3% | -6.5% | -17% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.7% | -1.4% | 21.7% |
| DIVIS LABORATORIES | 2% | 10.3% | 49.5% |
| TORRENT PHARMACEUTICALS | -0.4% | -0.5% | 38.6% |
| CIPLA | -0.5% | -2.5% | -10.2% |
| DR REDDYS LABORATORIES | -1.2% | 0% | -7.1% |
| MANKIND PHARMA | -1.5% | -3.3% | -4.6% |
| LUPIN | -0.6% | -9.4% | 13% |
| ZYDUS LIFESCIENCES | -3.2% | 2.9% | 19.2% |
ABBOTT INDIA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 6.09 % |
| Y-o-Y | 4.33 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹1,814 Cr | 6.09 | |
| Mar2026 | ₹1,710 Cr | -0.84 | |
| Dec2025 | ₹1,724 Cr | -1.88 | |
| Sep2025 | ₹1,757 Cr | 1.08 | |
| Jun2025 | ₹1,738 Cr | 8.34 | |
| Mar2025 | ₹1,605 Cr | -0.60 | |
| Dec2024 | ₹1,614 Cr | -1.13 | |
| Sep2024 | ₹1,633 Cr | - | |
ABBOTT INDIA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 8.66 % |
| Y-o-Y | 17.26 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹523 Cr | 8.66 | |
| Mar2026 | ₹481 Cr | 3.75 | |
| Dec2025 | ₹463 Cr | -7.71 | |
| Sep2025 | ₹502 Cr | 12.70 | |
| Jun2025 | ₹446 Cr | 3.98 | |
| Mar2025 | ₹429 Cr | -1.73 | |
| Dec2024 | ₹436 Cr | -0.65 | |
| Sep2024 | ₹439 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 2.42 % |
| Y-o-Y | 12.41 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 28.81% | 2.42 | |
| Mar2026 | 28.13% | 4.65 | |
| Dec2025 | 26.88% | -5.95 | |
| Sep2025 | 28.58% | 11.51 | |
| Jun2025 | 25.63% | -4.04 | |
| Mar2025 | 26.71% | -1.11 | |
| Dec2024 | 27.01% | 0.45 | |
| Sep2024 | 26.89% | - | |
ABBOTT INDIA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 8.51 % |
| Y-o-Y | 17.13 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹429 Cr | 8.51 | |
| Mar2026 | ₹395 Cr | 5.05 | |
| Dec2025 | ₹376 Cr | -9.47 | |
| Sep2025 | ₹415 Cr | 13.51 | |
| Jun2025 | ₹366 Cr | -0.32 | |
| Mar2025 | ₹367 Cr | 1.74 | |
| Dec2024 | ₹361 Cr | 0.61 | |
| Sep2024 | ₹359 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 2.29 % |
| Y-o-Y | 12.26 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | 23.63 % | 2.29 | |
| Mar2026 | 23.1 % | 5.91 | |
| Dec2025 | 21.81 % | -7.70 | |
| Sep2025 | 23.63 % | 12.26 | |
| Jun2025 | 21.05 % | -7.96 | |
| Mar2025 | 22.87 % | 2.33 | |
| Dec2024 | 22.35 % | 1.78 | |
| Sep2024 | 21.96 % | - | |
ABBOTT INDIA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 8.51 % |
| Y-o-Y | 17.13 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹201.66 | 8.51 | |
| Mar2026 | ₹185.85 | 5.05 | |
| Dec2025 | ₹176.92 | -9.47 | |
| Sep2025 | ₹195.42 | 13.50 | |
| Jun2025 | ₹172.17 | -0.32 | |
| Mar2025 | ₹172.72 | 1.73 | |
| Dec2024 | ₹169.78 | 0.60 | |
| Sep2024 | ₹168.76 | - | |
You may also like the below Video Courses